On the stock market since 2011, it operates in the world of health and science. It has 10,543 employees. Now — the numbers.
This is an established company with proven profits.
No real growth (2% a year).
If every debt were paid off today, $59.7B would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
An investor who bought at the very peak is down 73% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
There is $247B in the vault; even if every debt were paid off, $59.7B would remain.
It pays out $1.04 per share each year — regular cash for whoever holds the stock.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
On our five-subject report card, ESALF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: ESALF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.